ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 80 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | – | 931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $85,866,000 | 42.72% |
| Versant Venture Management, LLC | 7,003,892 | $146,241,265,000 | 21.01% |
| ACUTA CAPITAL PARTNERS, LLC | 1,746,500 | $36,467,000 | 10.54% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $10,022,000 | 5.33% |
| Ghost Tree Capital, LLC | 900,000 | $18,792,000 | 4.96% |
| RTW INVESTMENTS, LP | 6,790,027 | $141,776,000 | 3.99% |
| RA Capital Management | 7,801,641 | $162,898,000 | 3.17% |
| Avoro Capital Advisors LLC | 7,585,000 | $158,375,000 | 3.13% |
| FRAZIER MANAGEMENT LLC | 1,437,028 | $30,005,000 | 2.64% |
| Soleus Capital Management, L.P. | 218,723 | $4,566,000 | 2.60% |